Middle East Dermal Fillers Market by Type (Hyaluronic Acid-Based, Hydroxylapatite-Based, Synthetic Polymer-Based, Collagen-Based), by Application (Facial Line Correction, Face-Lift, Lip Treatment), by End User (Dermatology Clinics, Hospitals), by Geography (Saudi Arabia, U.A.E) –Market Size, Share, Development, Growth, and Demand Forecast, 2013–2023

Chapter 1. Research Background

1.1 Research Objectives

1.2 Market Definition

1.3 Research Scope

1.3.1 Market Segmentation by Type

1.3.2 Market Segmentation by Application

1.3.3 Market Segmentation by End User

1.3.4 Market Segmentation by Geography

1.3.5 Analysis Period

1.3.6 Market Data Reporting Unit

1.3.6.1 Value

1.4 Key Stakeholders

Chapter 2. Research Methodology

2.1 Secondary Research

2.2 Primary Research

2.2.1 Breakdown of Primary Research Respondents

2.2.1.1 By country

2.2.1.2 By industry participant

2.2.1.3 By company type

2.3 Market Size Estimation

2.4 Data Triangulation

2.5 Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction

4.1 Definition of Market Segments

4.1.1 By Type

4.1.1.1 Hyaluronic acid-based dermal fillers

4.1.1.2 Hydroxylapatite-based dermal fillers

4.1.1.3 Synthetic polymer-based

4.1.1.4 Collagen-based dermal fillers

4.1.2 By Application

4.1.2.1 Facial line correction

4.1.2.2 Face-lift

4.1.2.3 Lip treatment

4.1.2.4 Others

4.1.3 By End User

4.1.3.1 Dermatology clinics

4.1.3.2 Hospitals

4.1.3.3 Others

4.2 Market Dynamics

4.2.1 Trends

4.2.1.1 Increasing demand for lip augmentation procedures

4.2.1.2 Shift in the preference for minimally invasive cosmetic surgeries

4.2.1.3 Growing product launches in the Middle East

4.2.2 Drivers

4.2.2.1 Increasing prevalence of skin problems

4.2.2.2 Growing aging population

4.2.2.3 Increasing awareness about age related skin problems

4.2.2.4 Thriving medical tourism industry

4.2.2.5 Increase in disposable income

4.2.2.6 Impact analysis of drivers on market forecast

4.2.3 Restraints

4.2.3.1 Stringent regulatory norms

4.2.3.2 Fear of social unacceptance or embarrassment

4.2.3.3 Side effects associated with dermal fillers

4.2.3.4 Impact analysis of restraints on market forecast

4.3 Porter’s Five Forces Analysis

4.3.1 Bargaining Power of Buyers

4.3.2 Bargaining Power of Suppliers

4.3.3 Threat of New Entrants

4.3.4 Intensity of Rivalry

4.3.5 Threat of Substitutes

Chapter 5. Middle East Market Size and Forecast

5.1 By Type

5.2 By Application

5.3 By End User

5.4 By Country

Chapter 6. Saudi Arabia Market Size and Forecast

6.1 By Type

6.2 By Application

6.3 By End User

Chapter 7. U.A.E. Market Size and Forecast

7.1 By Type

7.2 By Application

7.3 By End User

Chapter 8. Rest of Middle East Market Size and Forecast

8.1 By Type

8.2 By Application

8.3 By End User

Chapter 9. Competitive Landscape

9.1 Product Benchmarking of Key Players

9.2 Strategic Developments of Key Players

Chapter 10. Company Profiles

10.1 Allergan plc

10.1.1 Business Overview

10.1.2 Product and Service Offerings

10.1.3 Key Financial Summary

10.1.4 Strategic Growth Plans

10.2 Galderma S.A.

10.2.1 Business Overview

10.2.2 Product and Service Offerings

10.3 Merz Pharma GmbH & Co. KGaA

10.3.1 Business Overview

10.3.2 Product and Service Offerings

10.3.3 Key Financial Summary

10.3.4 Strategic Growth Plans

10.4 Sinclair Pharma plc

10.4.1 Business Overview

10.4.2 Product and Service Offerings

10.4.3 Key Financial Summary

10.4.4 Strategic Growth Plans

10.5 Teoxane Laboratories

10.5.1 Business Overview

10.5.2 Product and Service Offerings

Chapter 11. Appendix

11.1 Abbreviations

11.2 Sources and References

11.3 Related Reports

 

LIST OF TABLES

 

TABLE 1 ANALYSIS PERIOD OF THE STUDY

TABLE 2 DRIVERS FOR THE MARKET: IMPACT ANALYSIS

TABLE 3 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS

TABLE 4 MIDDLE EAST DERMAL FILLERS MARKET, BY TYPE, $’000 (2013–2017)

TABLE 5 MIDDLE EAST DERMAL FILLERS MARKET, BY TYPE, $’000 (2018–2023)

TABLE 6 MIDDLE EAST DERMAL FILLERS MARKET, BY APPLICATION, $’000 (2013–2017)

TABLE 7 MIDDLE EAST DERMAL FILLERS MARKET, BY APPLICATION, $’000 (2018–2023)

TABLE 8 MIDDLE EAST DERMAL FILLERS MARKET, BY END USER, $’000 (2013–2017)

TABLE 9 MIDDLE EAST DERMAL FILLERS MARKET, BY END USER, $’000 (2018–2023)

TABLE 10 MIDDLE EAST DERMAL FILLERS MARKET, BY COUNTRY, $’000 (2013–2017)

TABLE 11 MIDDLE EAST DERMAL FILLERS MARKET, BY COUNTRY, $’000 (2018–2023)

TABLE 12 SAUDI ARABIA DERMAL FILLERS MARKET, BY TYPE, $’000 (2013–2017)

TABLE 13 SAUDI ARABIA DERMAL FILLERS MARKET, BY TYPE, $’000 (2018–2023)

TABLE 14 SAUDI ARABIA DERMAL FILLERS MARKET, BY APPLICATION, $’000 (2013–2017)

TABLE 15 SAUDI ARABIA DERMAL FILLERS MARKET, BY APPLICATION, $’000 (2018–2023)

TABLE 16 SAUDI ARABIA DERMAL FILLERS MARKET, BY END USER, $’000 (2013–2017)

TABLE 17 SAUDI ARABIA DERMAL FILLERS MARKET, BY END USER, $’000 (2018–2023)

TABLE 18 U.A.E. DERMAL FILLERS MARKET, BY TYPE, $’000 (2013–2017)

TABLE 19 U.A.E. DERMAL FILLERS MARKET, BY TYPE, $’000 (2018–2023)

TABLE 20 U.A.E. DERMAL FILLERS MARKET, BY APPLICATION, $’000 (2013–2017)

TABLE 21 U.A.E. DERMAL FILLERS MARKET, BY APPLICATION, $’000 (2018–2023)

TABLE 22 U.A.E. DERMAL FILLERS MARKET, BY END USER, $’000 (2013–2017)

TABLE 23 U.A.E. DERMAL FILLERS MARKET, BY END USER, $’000 (2018–2023)

TABLE 24 REST OF MIDDLE EAST DERMAL FILLERS MARKET, BY TYPE, $’000 (2013–2017)

TABLE 25 REST OF MIDDLE EAST DERMAL FILLERS MARKET, BY TYPE, $’000 (2018–2023)

TABLE 26 REST OF MIDDLE EAST DERMAL FILLERS MARKET, BY APPLICATION, $’000 (2013–2017)

TABLE 27 REST OF MIDDLE EAST DERMAL FILLERS MARKET, BY APPLICATION, $’000 (2018–2023)

TABLE 28 REST OF MIDDLE EAST DERMAL FILLERS MARKET, BY END USER, $’000 (2013–2017)

TABLE 29 REST OF MIDDLE EAST DERMAL FILLERS MARKET, BY END USER, $’000 (2018–2023)

TABLE 30 ALLERGAN PLC – AT A GLANCE

TABLE 31 ALLERGAN PLC – KEY FINANCIAL SUMMARY

TABLE 32 GALDERMA S.A. – AT A GLANCE

TABLE 33 MERZ PHARMA GMBH & CO. KGAA – AT A GLANCE

TABLE 34 MERZ PHARMA GMBH & CO. KGAA – KEY FINANCIAL SUMMARY

TABLE 35 SINCLAIR PHARMA PLC – AT A GLANCE

TABLE 36 SINCLAIR PHARMA PLC – KEY FINANCIAL SUMMARY

TABLE 37 TEOXANE LABORATORIES – AT A GLANCE

 

LIST OF FIGURES

 

FIG 1 RESEARCH SCOPE

FIG 2 RESEARCH METHODOLOGY

FIG 3 GEOGRAPHICAL SPLIT OF PRIMARY AND SECONDARY RESEARCH

FIG 4 BREAKDOWN OF PRIMARY RESEARCH BY COUNTRY

FIG 5 BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT

FIG 6 BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE

FIG 7 DATA TRIANGULATION APPROACH

FIG 8 MIDDLE EAST DERMAL FILLERS MARKET SUMMARY

FIG 9 PORTER’S FIVE FORCES ANALYSIS

FIG 10 SNAPSHOT OF MIDDLE EAST DERMAL FILLERS MARKET

FIG 11 MIDDLE EAST DERMAL FILLERS MARKET, BY TYPE, $’000 (2013–2023)

FIG 12 MIDDLE EAST DERMAL FILLERS MARKET, BY APPLICATION, $’000 (2013–2023)

FIG 13 MIDDLE EAST DERMAL FILLERS MARKET, BY END USER, $’000 (2013–2023)

FIG 14 MAJOR MARKETS FOR DERMAL FILLERS IN MIDDLE EAST

FIG 15 SAUDI ARABIA DERMAL FILLERS MARKET SNAPSHOT

FIG 16 SAUDI ARABIA DERMAL FILLERS MARKET, BY TYPE, $’000 (2013–2023)

FIG 17 SAUDI ARABIA DERMAL FILLERS MARKET, BY APPLICATION, $’000 (2013–2023)

FIG 18 SAUDI ARABIA DERMAL FILLERS MARKET, BY END USER, $’000 (2013–2023)

FIG 19 U.A.E. DERMAL FILLERS MARKET SNAPSHOT

FIG 20 U.A.E. DERMAL FILLERS MARKET, BY TYPE, $’000 (2013–2023)

FIG 21 U.A.E. DERMAL FILLERS MARKET, BY APPLICATION, $’000 (2013–2023)

FIG 22 U.A.E. DERMAL FILLERS MARKET, BY END USER, $’000 (2013–2023)

FIG 23 REST OF MIDDLE EAST DERMAL FILLERS MARKET SNAPSHOT

FIG 24 REST OF MIDDLE EAST DERMAL FILLERS MARKET, BY TYPE, $’000 (2013–2023)

FIG 25 REST OF MIDDLE EAST DERMAL FILLERS MARKET, BY APPLICATION, $’000 (2013–2023)

FIG 26 REST OF MIDDLE EAST DERMAL FILLERS MARKET, BY END USER, $’000 (2013–2023)

FIG 27 PRODUCT BENCHMARKING OF KEY PLAYERS

FIG 28 ALLERGAN PLC – REVENUE SPLIT BY SEGMENT (2017)

FIG 29 MERZ PHARMA GMBH & CO. KGAA – REVENUE SPLIT BY GEOGRAPHY (2017)

FIG 30 SINCLAIR PHARMA PLC – REVENUE SPLIT BY GEOGRAPHY (2016)